NCT06805695View on ClinicalTrials.gov

Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

RecruitingOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

December 23, 2024

Primary Completion Date

July 31, 2041

Study Completion Date

July 31, 2041

Conditions
Ornithine Transcarbamylase DeficiencyOrnithine Transcarbamylase Deficiency DiseaseUrea Cycle Disorders, Inborn
Interventions
OTHER

No Intervention

No Intervention

Trial Locations (1)

Unknown

RECRUITING

Great Ormond Street Hospital, London

All Listed Sponsors
lead

iECURE, Inc.

INDUSTRY

NCT06805695 - Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP) | Biotech Hunter | Biotech Hunter